Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 6.11B P/E 29.99 EPS this Y 15.90% Ern Qtrly Grth -70.00%
Income 122.87M Forward P/E 22.70 EPS next Y 22.30% 50D Avg Chg 2.00%
Sales 1.57B PEG 1.16 EPS past 5Y 13.13% 200D Avg Chg -5.00%
Dividend N/A Price/Book 3.13 EPS next 5Y 16.20% 52W High Chg -25.00%
Recommedations 2.40 Quick Ratio 2.61 Shares Outstanding 112.94M 52W Low Chg 17.00%
Insider Own 0.79% ROA 4.77% Shares Float 111.92M Beta 1.10
Inst Own 96.98% ROE 4.21% Shares Shorted/Prior 7.76M/5.73M Price 59.69
Gross Margin 69.62% Profit Margin 7.83% Avg. Volume 999,509 Target Price 61.46
Oper. Margin 12.74% Earnings Date May 2 Volume 967,746 Change 1.20%
About Globus Medical, Inc.

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

GMED Chatroom

User Image Stock_Titan Posted - 3 days ago

$GMED Globus Medical Schedules First Quarter Earnings Release and Conference Call https://www.stocktitan.net/news/GMED/globus-medical-schedules-first-quarter-earnings-release-and-bo98cikr9k9d.html

User Image smartkarma Posted - 2 weeks ago

$GMED | Globus Medical Inc.: Initiation Of Coverage - Increasing Portfolio Range & 3 Critical Growth Factors "Globus Medical, a leading musculoskeletal solutions provider, has reported record revenues of $1.569 billion for the full year 2023, marking a..." - Baptista Research (Baptista Research) Key Points:Globus Medical, a leading musculoskeletal solutions provider, has reported record revenues of $1.569 billion for the full year 2023, marking a growth of 53% compared to the previous year.The strong performance includes four months of sales after its merger with NuVasive.This remarkable growth maintained the company's industry-leading profitability, generating a record non-GAAP EPS of $2.32 and an adjusted EBITDA of 30%. Read more: https://www.smartkarma.com/insights/globus-medical-inc-initiation-of-coverage-increasing-portfolio-range-3-critical-growth-factors

User Image insiderbuyingselling Posted - 1 month ago

$GMED new insider selling: 10590 shares. http://insiderbuyingselling.com/?t=GMED

User Image Thestocktraderhubzee Posted - 1 month ago

$GMED BTIG Upgrades Globus Medical to Buy, Announces $60 Price Target

User Image basscat12 Posted - 1 month ago

$GMED $PAGS $RF Highlighted Analyst Activity, page 3, courtesy @TheTradeXchange presented here for @Vegas1 to help prepare for market opportunities

User Image CeaseNDesist Posted - 1 month ago

$GMED

User Image Trader_Ty Posted - 1 month ago

$GMED Flagging

User Image CeaseNDesist Posted - 1 month ago

$GMED great place to have your money for the next 12 months or more

User Image Trader_Ty Posted - 1 month ago

$GMED Sitting above all my MAs on daily and weekly. Solid!

User Image Trader_Ty Posted - 1 month ago

$GMED Nice look

User Image Aigner_Andreas Posted - 02/27/24

#GoldenCross $GMED at 55.91 R7 HiLo 65% T1Y 72 buy DIV N/A #Globus Med #stocks #trading #finance #market

User Image TickerDD_com Posted - 02/26/24

From 2/16/2024, looking back across 22 Month-Ends for GMED, Percentage Change of Average Monthly Price had More Positives (59%) while Percentage Change of Average Monthly Volume had More Positives (91%) $GMED #GMED #GMEDStock #TickerDD #GMEDPrice https://www.youtube.com/watch?v=mXXg96UGVns

User Image CeaseNDesist Posted - 02/21/24

$GMED

User Image swingingtech Posted - 02/21/24

$GMED $CAH $SYK https://wallstreetwaves.com/globus-medical-gmed-q4-earnings-surpass-margins-down/

User Image DonCorleone77 Posted - 1 month ago

$GMED Globus Medical backs FY24 EPS view $2.68 to $2.70, consensus $2.69 Backs FY24 revenue view $2.45B-$2.48B, consensus $2.46B. The company said, "The Company reaffirms its full year 2024 revenue guidance range of $2.450 billion to $2.475 billion and fully diluted non-GAAP earnings per share range between $2.68 to $2.70."

User Image DonCorleone77 Posted - 1 month ago

$GMED Globus Medical reports Q4 EPS 60c, consensus 61c Reports Q4 revenue $616.53M, consensus $608.04M. "I am pleased to report on the remarkable progress we've made at Globus Medical. Our merger with NuVasive has been a transformative milestone, where we pursue a vision of providing the best innovative technology and most dedicated level of customer service for our surgeons and their patients," said Dan Scavilla, president and CEO. "The integration is progressing according to plan, underscoring our commitment to a seamless transition and operational efficiency. Looking ahead to 2024, the pipeline of product launches, especially in enabling technologies, aligns with our philosophy of anticipating and meeting evolving customer needs. We recognize the importance of staying ahead of the curve, a principle that guides our approach to innovation and client service. I believe the potential for Globus has never been greater, as we continue to redefine spine surgery..."

User Image Estimize Posted - 1 month ago

$GMED reports inline with the Estimize EPS Consensus and misses the Estimize Revenue Consensus by $1.94M. Reports FQ4 earnings of 60c E... http://www.estimize.com/gmed/fq4-2023?utm_content=beat_or_miss&utm_medium=tweet&utm_source=stocktwits

User Image epsguid Posted - 1 month ago

$GMED reported earnings of $0.60, consensus was $0.59, Earnings Whisper was $0.62 via @eWhispers #whispermiss http://eps.sh/d/gmed

User Image Stock_Titan Posted - 1 month ago

$GMED Globus Medical Reports Fourth Quarter and Full Year 2023 Results https://www.stocktitan.net/news/GMED/globus-medical-reports-fourth-quarter-and-full-year-2023-l5bmnq8toxzf.html

User Image Estimize Posted - 2 months ago

$GMED reports after the close, Estimize Consensus +0.01 EPS and +10.26M Revs compared to WS http://www.estimize.com/gmed/fq4-2023?utm_content=prerelease&utm_medium=tweet&utm_source=stocktwits

User Image swingingtech Posted - 2 months ago

$CYH, $AMED, $CDXS, $GMED https://wallstreetwaves.com/can-low-patient-days-affect-community-health-cyh-q4-earnings/

User Image swingingtech Posted - 2 months ago

$TDOC $AMED $GMED $CDXS https://wallstreetwaves.com/higher-visits-to-soften-cost-blow-for-teladoc-tdoc-q4-earnings/

User Image Stock_Titan Posted - 2 months ago

$GMED Globus Medical Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call https://www.stocktitan.net/news/GMED/globus-medical-schedules-fourth-quarter-and-full-year-2023-earnings-122v1ekl9znf.html

User Image Stock_Titan Posted - 2 months ago

$GMED Globus Medical promotes Keith Pfeil to Chief Operating Officer and Chief Financial Officer https://www.stocktitan.net/news/GMED/globus-medical-promotes-keith-pfeil-to-chief-operating-officer-and-rafaqv02294f.html

User Image Aigner_Andreas Posted - 2 months ago

TD BUY $GMED at 51.83, Supp 51.83 Resis 56.52 R9 HiLo 24% T1Y 72 buy 2.1 DIV N/A #Globus Med #stocks #trading #finance #market

User Image tickeron Posted - 01/24/24

Good move or bad move? $GMED MACD Histogram turned negative on January 23, 2024. View odds of downtrend. https://srnk.us/go/4977376

User Image swingingtech Posted - 01/23/24

$GMED $HAE $DVA $HQY https://wallstreetwaves.com/heres-why-you-should-retain-globus-medical-gmed-stock-now-2/

User Image shortvolumes Posted - 01/21/24

2024-01-19 Short sale volume (not short interest) for $GMED is 74%. http://shortvolumes.com/?t=GMED via @shortvolumes

User Image UltraAlgo Posted - 3 months ago

$GMED Sell Rating from 10 signals, 15-min ticks 🚀 Chart by UltraAlgo https://i.redd.it/vr6ovn8m1vcc1.png

User Image ChartMill Posted - 3 months ago

$GMED: Despite its growth, GLOBUS MEDICAL INC - A (NYSE:$GMED) remains within the realm of affordability. https://www.chartmill.com/news/GMED/Chartmill-16893-Despite-its-growth-NYSE-GMED-remains-within-the-realm-of-affordability?utm_source=Chartmill-16893-Despite-its-growth-NYSE-GMED-remains-within-the-realm-of-affordability&utm_medium=stocktwits&utm_campaign=blog&utm_content=GMED

Analyst Ratings
BTIG Buy Mar 18, 24
Stifel Buy Feb 21, 24
Truist Securities Hold Feb 21, 24
RBC Capital Outperform Jan 11, 24
Truist Securities Hold Dec 22, 23
Canaccord Genuity Buy Dec 20, 23
Morgan Stanley Equal-Weight Nov 14, 23
Truist Securities Hold Nov 8, 23
Roth MKM Buy Oct 20, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Pfeil Keith W SVP, Chief Financial.. SVP, Chief Financial Officer Feb 02 Sell 77.57 29,167 2,262,484 02/06/23
Pfeil Keith W SVP, Chief Financial.. SVP, Chief Financial Officer Feb 02 Option 51.46 29,167 1,500,934 29,167 02/06/23
Pfeil Keith W SVP, Chief Financial.. SVP, Chief Financial Officer Aug 19 Sell 76.13 833 63,416 02/06/23
Pfeil Keith W SVP, Chief Financial.. SVP, Chief Financial Officer Aug 19 Option 49.65 833 41,358 833 02/06/23
Davidar David D Director Director Apr 19 Sell 78.034 31,500 2,458,071 601,275 04/21/22
Huller Kelly SVP, GC, Corporate S.. SVP, GC, Corporate Secretary Apr 08 Option 15.34 2,500 38,350 2,500 04/11/22
Huller Kelly SVP, GC, Corporate S.. SVP, GC, Corporate Secretary Apr 08 Sell 75.59 2,500 188,975 04/11/22
TOBIN JAMES R Director Director Mar 08 Sell 71.02 14,484 1,028,654 03/10/22
TOBIN JAMES R Director Director Mar 08 Option 43.58 14,484 631,213 10,000 03/10/22
Pfeil Keith W SVP, Chief Financial.. SVP, Chief Financial Officer Aug 23 Sell 76.13 833 63,416 08/23/21
Pfeil Keith W SVP, Chief Financial.. SVP, Chief Financial Officer Aug 23 Option 53.27 833 44,374 833 08/23/21
Lemaitre Dan Director Director Mar 11 Option 11.28 15,384 173,532 15,384 03/11/21
Lemaitre Dan Director Director Mar 11 Sell 62.47 15,384 961,038 03/11/21
Huller Kelly SVP, GC, Corporate S.. SVP, GC, Corporate Secretary Dec 29 Option 11.28 2,000 22,560 2,000 12/29/20
Huller Kelly SVP, GC, Corporate S.. SVP, GC, Corporate Secretary Dec 29 Sell 66.15 2,000 132,300 12/29/20
Demski David M President, CEO President, CEO Dec 18 Option 38.89 330,000 12,833,700 478,855 12/18/20
Demski David M President, CEO President, CEO Dec 18 Sell 56.23 330,000 18,555,900 148,855 12/18/20